These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27826760)

  • 1. Myotonic Dystrophy Type 1 Management and Therapeutics.
    Smith CA; Gutmann L
    Curr Treat Options Neurol; 2016 Dec; 18(12):52. PubMed ID: 27826760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.
    LoRusso S; Weiner B; Arnold WD
    Neurotherapeutics; 2018 Oct; 15(4):872-884. PubMed ID: 30341596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.
    Ho G; Cardamone M; Farrar M
    World J Clin Pediatr; 2015 Nov; 4(4):66-80. PubMed ID: 26566479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1.
    Boentert M; Cao M; Mass D; De Mattia E; Falcier E; Goncalves M; Holland V; Katz SL; Orlikowski D; Sannicolò G; Wijkstra P; Hellerstein L; Sansone VA
    Respiration; 2020; 99(4):360-368. PubMed ID: 32299079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy: from bench to bedside.
    Johnson NE; Heatwole CR
    Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1.
    Urata Y; Nakamura M; Shiokawa N; Yasuniwa A; Takamori N; Imamura K; Hayashi T; Ishizuka T; Kasugai M; Sano A
    Front Neurol; 2020; 11():12. PubMed ID: 32117000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.
    Gibbs JW; Ciafaloni E; Radtke RA
    Sleep; 2002 Sep; 25(6):662-5. PubMed ID: 12224846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximal myotonic dystrophy--a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes?
    Udd B; Krahe R; Wallgren-Pettersson C; Falck B; Kalimo H
    Neuromuscul Disord; 1997 Jun; 7(4):217-28. PubMed ID: 9196902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.
    Wood L; Cordts I; Atalaia A; Marini-Bettolo C; Maddison P; Phillips M; Roberts M; Rogers M; Hammans S; Straub V; Petty R; Orrell R; Monckton DG; Nikolenko N; Jimenez-Moreno AC; Thompson R; Hilton-Jones D; Turner C; Lochmüller H
    J Neurol; 2017 May; 264(5):979-988. PubMed ID: 28397002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic Dystrophy Type 1 or Steinert's disease.
    Romeo V
    Adv Exp Med Biol; 2012; 724():239-57. PubMed ID: 22411247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
    Jean S; Richer L; Laberge L; Mathieu J
    Orphanet J Rare Dis; 2014 Nov; 9():186. PubMed ID: 25424323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
    Finsterer J; Rudnik-Schöneborn S
    Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotonic Muscular Dystrophies.
    Johnson NE
    Continuum (Minneap Minn); 2019 Dec; 25(6):1682-1695. PubMed ID: 31794466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophies type 1 and 2: a summary on current aspects.
    Schara U; Schoser BG
    Semin Pediatr Neurol; 2006 Jun; 13(2):71-9. PubMed ID: 17027856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
    Meola G; Cardani R
    Neurol Sci; 2017 Apr; 38(4):535-546. PubMed ID: 28078562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.
    De Antonio M; Dogan C; Hamroun D; Mati M; Zerrouki S; Eymard B; Katsahian S; Bassez G;
    Rev Neurol (Paris); 2016 Oct; 172(10):572-580. PubMed ID: 27665240
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.